Publications
Print PDF
AbbVie Enters the Battle of the Biosimilars
January 15, 2016
Khadijah M. Silver
Institutional Investor

Axinn partner Chad Landmon was quoted in the Institutional Investor's article, "AbbVie Enters the Battle of the Biosimilars."

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.